INDOCO REMEDIES
Back to Balance Sheet
|
INDOCO REMEDIES Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹163 Cr | ₹164 Cr | ₹89 Cr | ₹60 Cr | ₹56 Cr |
What is the latest Contingent Liabilities ratio of INDOCO REMEDIES ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹163 Cr |
| Mar2024 | ₹164 Cr |
| Mar2023 | ₹89 Cr |
| Mar2022 | ₹60 Cr |
| Mar2021 | ₹56 Cr |
How is Contingent Liabilities of INDOCO REMEDIES Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹163 Cr | -0.60 | |
| Mar2024 | ₹164 Cr | 83.75 | |
| Mar2023 | ₹89 Cr | 48.09 | |
| Mar2022 | ₹60 Cr | 7.79 | |
| Mar2021 | ₹56 Cr | - | |
Compare Contingent Liabilities of peers of INDOCO REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDOCO REMEDIES | ₹2,402.3 Cr | -5.6% | -6.8% | -11.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,147.0 Cr | -1.1% | 1.9% | -8.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,708.0 Cr | 3.5% | 18.2% | 15.4% | Stock Analytics | |
| CIPLA | ₹121,525.0 Cr | -2.6% | -0.9% | -3.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹121,147.0 Cr | -1.3% | 0.8% | 11.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,596.0 Cr | 0.2% | -3.5% | -5.8% | Stock Analytics | |
INDOCO REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDOCO REMEDIES | -5.6% |
-6.8% |
-11.9% |
| SENSEX | -1.4% |
1.7% |
4.8% |
You may also like the below Video Courses